B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Defosbarasertib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Defosbarasertib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

cediranib
40 shared targets
quizartinib
37 shared targets
vandetanib
46 shared targets
foretinib
66 shared targets
raf
33 shared targets
canertinib
43 shared targets
tandutinib
26 shared targets
linifanib
39 shared targets
pazopanib
40 shared targets
plx
34 shared targets
Loading evidence profile...

This evidence profile for Defosbarasertib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.